Goldman Sachs Starts Heartware Int'l (HTWR) at Neutral; Solid Technology but See Little Upside

Goldman Sachs initiates coverage on Heartware Int'l (NASDAQ: HTWR) with a Neutral. PT $93.00.

Analyst, David H. Roman, said, "Longer-term, HeartWare should benefit from the expanding LVAD market and a product pipeline. As with THOR, we think HTWR is also a strategic asset. That said, consensus sales projections appear too optimistic with regard to launch trajectory and market share capture. This could prove a headwind for the stock with shares up 30% YTD vs. the Russell 2000 up 7%. We would look for either better business performance or a recalibration of expectations to become more constructive."

For an analyst ratings summary and ratings history on Heartware Int'l click here. For more ratings news on Heartware Int'l click here.

Shares of Heartware Int'l closed at $89.68 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
• Evercore ISI Starts Alvotech SA (ALVO) at Outperform